Molecular Partners AG MLLCF
MLLCF
Molecular Partners AG BXPHF
Botanix Pharmaceuticals Limited IPHYF
Innate Pharma S.A. NDTP
NDT Pharmaceuticals Inc. BRIBF
Brii Biosciences Limited SCNLF
Scancell Holdings plc JWCTF
JW (Cayman) Therapeutics Co. Ltd NGENF
NervGen Pharma Corp. AAWH
Ascend Wellness Holdings, Inc. SPHDF
Santhera Pharmaceuticals Holding AG
Molecular Partners AG BXPHF
Botanix Pharmaceuticals Limited IPHYF
Innate Pharma S.A. NDTP
NDT Pharmaceuticals Inc. BRIBF
Brii Biosciences Limited SCNLF
Scancell Holdings plc JWCTF
JW (Cayman) Therapeutics Co. Ltd NGENF
NervGen Pharma Corp. AAWH
Ascend Wellness Holdings, Inc. SPHDF
Santhera Pharmaceuticals Holding AG
Performance
| Periode | MLLCF | BXPHF | IPHYF | NDTP | BRIBF | SCNLF | JWCTF | NGENF | AAWH | SPHDF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -17.06 % | -72.81 % | 10.51 % | 1 266.91 % | -7.46 % | 21.01 % | 44.00 % | 95.57 % | 146.12 % | -9.49 % |
| YTD | -14.84 % | -75.36 % | -25.69 % | 3 484.91 % | 91.79 % | -20.00 % | 122.22 % | 128.45 % | 66.43 % | 41.72 % |
| 1Y | -14.84 % | -75.36 % | -25.69 % | 3 484.91 % | 91.79 % | -20.00 % | 123.05 % | 143.12 % | 98.57 % | 41.72 % |
| 3Y | -41.28 % | 215.40 % | -31.15 % | 1 800.00 % | -74.67 % | -10.00 % | -29.36 % | 324.00 % | -38.48 % | -99.05 % |
| 5Y | -85.42 % | -28.32 % | -49.88 % | -47.22 % | -91.25 % | 79.33 % | -87.37 % | 217.37 % | -92.49 % | 41 076 823.08 % |
| 10Y | -84.53 % | -60.58 % | -84.85 % | 1 800.00 % | -91.25 % | -40.74 % | -87.37 % | 307.47 % | -92.49 % | 1 530 963 302 652.29 % |
| From the beginning | -84.53 % | -60.58 % | -86.12 % | -99.63 % | -91.25 % | -68.00 % | -87.37 % | 307.47 % | -92.49 % | 29 666 666 566.67 % |